3Unwin N,Shaw J, Zimmet P. International Diabetes Federation IGF/IGT consensus statement. Impaired glucose tolerance and impaired fadting glycaemia: The current status on definition and intervention[J]. Diabetic Med, 2002,19: 708 - 723. 被引量：1
4Grundy S N, Reeker D, Clark L T, et al. National cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel Ⅲ ) [J]. JAMA, 2001,285: 2486 - 2497. 被引量：1
5Looker H C, Knowler W C, Hanson R L. Changes in BMI and weight before and after the development of type 2 diabetes [J]. Diabetes Care,2001,24:1917 - 1923. 被引量：1
6Klewer S A, Xu H E, Lambert M H, et al. Peroxisome proliferatoractivated receptors: From genes to physiology[J]. Recent Prog Horm Res, 2001,56: 239 - 263. 被引量：1
7Hammarstedt A, Smith U. PPAR gamma, but not PPAR alpha, ligands increase IRS- 1 gene and protein expression in L6 muscle cells[J]. Diabetes, 2001,50: A409. 被引量：1
8HOPE Research Group. Angiotensin converting engyme inhibitor- effect of ramipril on cardiovascular events in high risk patients[J]. N Engl J Med,2000,342:311 - 316. 被引量：1
9American Diabetes Association. Screening for diabetes [J]. Diabetes Care, 2002,25 (suppl1): 21 - 24. 被引量：1
10Narayan K M V, Imperatore G, Benjamin S M, et al. Targting people with pre - diabetes[J]. BMJ, 2002,325: 403 - 404. 被引量：1
